EXPESSION AND SIGNIFICANCE OF ARL2 AND THE RELATIONSHIP WITH AXL AND STAT3 IN COLORECTAL CANCER

被引:0
|
作者
Pang, Xunlei [1 ]
Cui, Yingying [2 ]
Wang, Yanhong [1 ]
Cao, Kai [2 ]
Miao, Bei [1 ]
Fei, Sujuan [1 ]
机构
[1] Xuzhou Med Univ, Dept Gastroenterol, Affiliated Hosp, Xuzhou, Jiangsu, Peoples R China
[2] Xuzhou Med Univ, Pathol Dept, Affiliated Hosp, Xuzhou, Jiangsu, Peoples R China
来源
ACTA MEDICA MEDITERRANEA | 2021年 / 37卷 / 01期
关键词
ARL2; AXL; STAT3; colorectal cancer; MITOCHONDRIAL-FUNCTION; GROWTH; P53;
D O I
10.19193/0393-6384_2021_1_98
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To study the expression and significance of ARL2 and the relationship with AXL and STAT3 in Colorectal Cancer (CRC). Methods: Altogether 182 patients with CRC confirmed by histopathological examination admitted to the general surgery on January 1, 2014 to December 31, 2014 were chosen to study objects. Survival follow-up was completed by December 31, 2019 by telephone. The expression of ARL2, AXL and STAT3 in 182 CRC tissues and adjacent tissues were detected by the tissue microarray and immunohistochemistry. SPSS 20.0 software was used for statistical processing. Kaplan-Meier method used to drawn the survival curve, log-rank method used for survival univariate analysis, and Cox model used for the survival multiple factor analysis. Results: The expression level of ARL2, AXL and STAT3 was increased in CRC tissues. ARL2 can be an independent prognostic factor for CRC. The expression level of ARL2 in phase I and. is higher than phase. and IV, while the expression of AXL in phase I and. is lower than phase. and IV (TNM staging) (P<0.05). The expression level of AXL and STAT3 is higher in the distant metastasis group (P<0.05). ARL2 positive expression was significantly increased in the survival group (P<0.05). The expression levels of ARL2 and AXL in CRC tissues were negatively correlated by Spearman rank correlation analysis(r=-0.375, p<0.001). ARL2 was positively related to STAT3 in CRC tissues (r=0.970, p<0.001). AXL was negatively related to STAT3 expression in CRC tissues (r=-0.332, p<0.001). The 5-year CRC survival rate of the ARL2 group with high expression level of different tumor sites, gender, TNM stage and lymph node metastasis group was all higher than that of the ARL2 group with low expression. Whereas, there was no difference in the 5-year survival rate of CRC with the expression level of ARL2 in the group under 65 years of age, and no difference in the expression level of ARL2 in the distant metastasis group. Conclusion: It was a highly expression of ARL2 in CRC tissues, furthermore high expression of ARL2 improved 5-year survival in CRC. ARL2 maybe affect the expression of AXL negatively and is critical to the development and progress of CRC, and ARL2 played an vital part in the formation, invasion and metastasis of CRC. This study can provide a preliminary assessment of the prognosis of CRC, and ARL2 could be a curative target for CRC.
引用
收藏
页码:637 / 644
页数:8
相关论文
共 50 条
  • [21] MULTIFUNCTIONAL DNA NANOSTRUCTURES FOR SELECTIVE TARGETING OF STAT3 IN COLORECTAL CANCER
    Pacifico, T.
    Unida, V
    Tomassini, L.
    Laudisi, F.
    Ortenzi, A.
    Colantoni, A.
    Monteleone, G.
    Biocca, S.
    Stolfi, C.
    DIGESTIVE AND LIVER DISEASE, 2024, 56 : S141 - S141
  • [22] Stat3 is a potential molecular target for chemoradiosensitization of colorectal cancer cells
    Spitzner, Melanie
    Roesler, Birte
    Bielfeld, Christian
    Gaedcke, Jochen
    Rave-Fraenk, Margret
    Beissbarth, Tim
    Ried, Thomas
    Ghadimi, B. Michael
    Grade, Marian
    CANCER RESEARCH, 2012, 72
  • [23] STAT3 Regulates the Expression and the Transcriptional Activity of β-Catenin in Colorectal Cancer
    Ibrahem, S.
    Baloch, K.
    Al-Ghamdi, S.
    Muhammad, B.
    Nateri, A. S.
    Ilyas, M.
    JOURNAL OF PATHOLOGY, 2011, 224 : S17 - S17
  • [24] Activation of STAT3 is a marker of poor prognosis in human colorectal cancer
    Kusaba, Takafumi
    Nakayama, Toshiyuki
    Yamazumi, Kazuyuki
    Yakata, Yuichi
    Yoshizaki, Ayumi
    Inoue, Kenichiro
    Nagayasu, Takeshi
    Sekine, Ichiro
    ONCOLOGY REPORTS, 2006, 15 (06) : 1445 - 1451
  • [25] STAT3 inhibition sensitizes colorectal cancer to chemoradiotherapy in vitro and in vivo
    Spitzner, Melanie
    Roesler, Birte
    Bielfeld, Christian
    Emons, Georg
    Gaedcke, Jochen
    Wolff, Hendrik A.
    Rave-Fraenk, Margret
    Kramer, Frank
    Beissbarth, Tim
    Kitz, Julia
    Wienands, Juergen
    Ghadimi, B. Michael
    Ebner, Reinhard
    Ried, Thomas
    Grade, Marian
    INTERNATIONAL JOURNAL OF CANCER, 2014, 134 (04) : 997 - 1007
  • [26] A New STAT3-binding Partner, ARL3, Enhances the Phosphorylation and Nuclear Accumulation of STAT3
    Togi, Sumihito
    Muromoto, Ryuta
    Hirashima, Koki
    Kitai, Yuichi
    Okayama, Taichiro
    Ikeda, Osamu
    Matsumoto, Naoki
    Kon, Shigeyuki
    Sekine, Yuichi
    Oritani, Kenji
    Matsuda, Tadashi
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (21) : 11161 - 11171
  • [27] Cryptotanshinone, a Stat3 inhibitor, suppresses colorectal cancer proliferation and growth in vitro
    Li, Weidong
    Saud, Shakir M.
    Young, Matthew R.
    Colburn, Nancy H.
    Hua, Baojin
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2015, 406 (1-2) : 63 - 73
  • [28] Interplay of miRNAs and lncRNAs in STAT3 signaling pathway in colorectal cancer progression
    Rahbar Farzam, Omid
    Najafi, Souzan
    Amini, Mohammad
    Rahimi, Zohreh
    Dabbaghipour, Reza
    Zohdi, Omid
    Asemani Shahgoli, Ghazale
    Baradaran, Behzad
    Akbari, Bahman
    CANCER CELL INTERNATIONAL, 2024, 24 (01)
  • [29] Effects and mechanism of STAT3 silencing on the growth and apoptosis of colorectal cancer cells
    Li, Jing
    Liu, You-Yu
    Yang, Xue-Feng
    Shen, Dao-Fu
    Sun, Hong-Zhi
    Huang, Ke-Qiang
    Zheng, Hua-Chuan
    ONCOLOGY LETTERS, 2018, 16 (05) : 5575 - 5582
  • [30] Interplay of miRNAs and lncRNAs in STAT3 signaling pathway in colorectal cancer progression
    Omid Rahbar Farzam
    Souzan Najafi
    Mohammad Amini
    Zohreh Rahimi
    Reza Dabbaghipour
    Omid Zohdi
    Ghazale Asemani Shahgoli
    Behzad Baradaran
    Bahman Akbari
    Cancer Cell International, 24